Literature DB >> 12958087

Social anxiety disorder.

Franklin R Schneier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12958087      PMCID： PMC192835          DOI： 10.1136/bmj.327.7414.515

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.

Authors:  R G Heimberg; M R Liebowitz; D A Hope; F R Schneier; C S Holt; L A Welkowitz; H R Juster; R Campeas; M A Bruch; M Cloitre; B Fallon; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1998-12

2.  Increased amygdala activation to angry and contemptuous faces in generalized social phobia.

Authors:  Murray B Stein; Philippe R Goldin; Jitender Sareen; Lisa T Eyler Zorrilla; Gregory G Brown
Journal:  Arch Gen Psychiatry       Date:  2002-11

Review 3.  Epidemiology, patterns of comorbidity, and associated disabilities of social phobia.

Authors:  H U Wittchen; L Fehm
Journal:  Psychiatr Clin North Am       Date:  2001-12

4.  Adolescent social anxiety as an outcome of inhibited temperament in childhood.

Authors:  C E Schwartz; N Snidman; J Kagan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-08       Impact factor: 8.829

5.  Different ages of onset in varieties of phobia.

Authors:  I M Marks; M G Gelder
Journal:  Am J Psychiatry       Date:  1966-08       Impact factor: 18.112

6.  Placebo-controlled trial of moclobemide in social phobia.

Authors:  F R Schneier; D Goetz; R Campeas; B Fallon; R Marshall; M R Liebowitz
Journal:  Br J Psychiatry       Date:  1998-01       Impact factor: 9.319

7.  Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.

Authors:  M R Liebowitz; R G Heimberg; F R Schneier; D A Hope; S Davies; C S Holt; D Goetz; H R Juster; S H Lin; M A Bruch; R D Marshall; D F Klein
Journal:  Depress Anxiety       Date:  1999       Impact factor: 6.505

8.  Generalized social phobia. Reliability and validity.

Authors:  S Mannuzza; F R Schneier; T F Chapman; M R Liebowitz; D F Klein; A J Fyer
Journal:  Arch Gen Psychiatry       Date:  1995-03

9.  Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

Authors:  M B Stein; M R Liebowitz; R B Lydiard; C D Pitts; W Bushnell; I Gergel
Journal:  JAMA       Date:  1998-08-26       Impact factor: 56.272

10.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01
View more
  12 in total

1.  Social anxiety disorder has social and economic burden.

Authors:  Antonio E Nardi
Journal:  BMJ       Date:  2003-11-29

2.  Psychological impact of alopecia: alopecia may lead to social anxiety.

Authors:  Antonio E Nardi
Journal:  BMJ       Date:  2005-11-05

3.  The impact of anxiety on social decision-making: behavioral and electrodermal findings.

Authors:  Tingting Wu; Yi Luo; Lucas S Broster; Ruolei Gu; Yue-jia Luo
Journal:  Soc Neurosci       Date:  2012-06-06       Impact factor: 2.083

4.  miR-124 regulates early isolation-induced social abnormalities via inhibiting myelinogenesis in the medial prefrontal cortex.

Authors:  Yanli Zhang; Yingting Pang; Weixi Feng; Yuxi Jin; Sijia Chen; Shixin Ding; Ze Wang; Ying Zou; Yun Li; Tianqi Wang; Peng Sun; Junying Gao; Yi Zhu; Xiaoyan Ke; Charles Marshall; Huang Huang; Chengyu Sheng; Ming Xiao
Journal:  Cell Mol Life Sci       Date:  2022-09-04       Impact factor: 9.207

5.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Authors:  Murray B Stein; Mark H Pollack; Alexander Bystritsky; Jeffrey E Kelsey; Richard M Mangano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

6.  Stimulus-reinforcement-based decision making and anxiety: impairment in generalized anxiety disorder (GAD) but not in generalized social phobia (GSP).

Authors:  J DeVido; M Jones; M Geraci; N Hollon; R J R Blair; D S Pine; K Blair
Journal:  Psychol Med       Date:  2008-12-22       Impact factor: 7.723

7.  Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders.

Authors:  Karina Blair; Jonathan Shaywitz; Bruce W Smith; Rebecca Rhodes; Marilla Geraci; Matthew Jones; Daniel McCaffrey; Meena Vythilingam; Elizabeth Finger; Krystal Mondillo; Madeline Jacobs; Dennis S Charney; R J R Blair; Wayne C Drevets; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2008-05-15       Impact factor: 18.112

8.  Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder.

Authors:  Murray B Stein; Soraya Seedat; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

9.  Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population.

Authors:  Lydia Fehm; Katja Beesdo; Frank Jacobi; Agnes Fiedler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-14       Impact factor: 4.328

10.  Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Social Anxiety Disorder: Case Reports and a Review of the Literature.

Authors:  Flávia Paes; Tathiana Baczynski; Felipe Novaes; Tamires Marinho; Oscar Arias-Carrión; Henning Budde; Alexander T Sack; Joseph P Huston; Leonardo Ferreira Almada; Mauro Carta; Adriana Cardoso Silva; Antonio E Nardi; Sergio Machado
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.